key: cord-0709981-azg5sysh
authors: Hellenbrand, Katrina M.; Forsythe, Katelyn M.; Rivera-Rivas, Jose J.; Czuprynski, Charles J.; Aulik, Nicole A.
title: Histophilus somni causes extracellular trap formation by bovine neutrophils and macrophages
date: 2012-09-27
journal: Microb Pathog
DOI: 10.1016/j.micpath.2012.09.007
sha: 9c4033fa0e4e46bd1822ea61fdd5964c1355a499
doc_id: 709981
cord_uid: azg5sysh

Histophilus somni (formerly Haemophilus somnus) is a Gram-negative pleomorphic coccobacillus that causes respiratory, reproductive, cardiac and neuronal diseases in cattle. H. somni is a member of the bovine respiratory disease complex that causes severe bronchopneumonia in cattle. Previously, it has been reported that bovine neutrophils and macrophages have limited ability to phagocytose and kill H. somni. Recently, it was discovered that bovine neutrophils and macrophages produce extracellular traps in response to Mannheimia haemolytica, another member of the bovine respiratory disease complex. In this study, we demonstrate that H. somni also causes extracellular trap production by bovine neutrophils in a dose- and time-dependent manner, which did not coincide with the release of lactate dehydrogenase, a marker for necrosis. Neutrophil extracellular traps were produced in response to outer membrane vesicles, but not lipooligosacchride alone. Using scanning electron microscopy and confocal microscopy, we observed H. somni cells trapped within a web-like structure. Further analyses demonstrated that bovine neutrophils trapped and killed H. somni in a DNA-dependent manner. Treatment of DNA extracellular traps with DNase I freed H. somni cells and diminished bacterial death. Treatment of bovine monocyte-derived macrophages with H. somni cells also caused macrophage extracellular trap formation. These findings suggest that extracellular traps may play a role in the host response to H. somni infection in cattle.

Bovine respiratory disease (BRD) is a leading cause of economic loss to the dairy and beef industries. An estimated 25 percent of calves experience respiratory illness in the first year of life [1, 2] . BRD is a multi-factorial disease caused by a combination of viral and bacterial pathogens [3] . Several viruses, including bovine herpes virus-1, bovine respiratory syncytial virus, parainfluenza-3, bovine viral diarrhea virus, and bovine coronavirus have been implicated in the initiation of BRD. These in turn predispose cattle to severe secondary infection by bacterial pathogens such as Mannheimia haemolytica, Histophilus somni, Pasteurella multocida, Mycoplasma bovis, and Arcanobacterium pyogenes [3] .

H. somni is a Gram-negative, pleomorphic coccobacillus that resides in the upper respiratory and reproductive tracts of diary and beef cattle. H. somni is an opportunistic pathogen that causes a wide variety of clinical syndromes such as pneumonia, reproductive disease, polyarthritis, septicemia, myocarditis and an acute neurological disease known as thrombotic meningoencephalitis [4, 5] . Despite being a normal resident of the microflora, H. somni has a variety of virulence factors including phosphocholine modification, phase variation of its lipooligosacchride (LOS), exopolysacchride production and secreted immunoglobulin Fc binding proteins such as IbpA [6] . H. somni also inhibits oxygen radical formation by bovine leukocytes [5] . Co-incubation of H. somni with bovine alveolar macrophages, blood monocytes and neutrophils reduces the ability of these cells to phagocytose, produce oxygen radicals and kill the bacteria. Those H. somni cells that are phagocytosed appear to survive within the leukocytes despite the production of nitric oxide [5] . Viable H. somni cells, but not killed cells nor culture supernatant, impair leukocyte function [5] .

Neutrophil extracellular trap (NET) formation is an active form of cell death in which activated neutrophils release nuclear deoxyribonucleic acid (DNA) that is studded with antimicrobial proteins such as elastase, histones, and myeloperoxidase [7e9] . NETs are produced by human, murine, bovine, fish, feline and chicken leukocytes [7,10e17] in response to prokaryotic and eukaryotic pathogens [18] . Upon formation, NETs can trap and kill a wide variety of Gram-positive and Gram-negative bacteria, fungi, protozoa [18] and viruses [19] . NET formation results in little or no lactate dehydrogenase (LDH) release, indicating that necrosis is not the chief cause of DNA release [7] . Similarly, NET formation occurs in the presence of inhibitors of apoptosis [20, 21] .

In addition to neutrophils, macrophages, mast cells, and eosinophils also produce extracellular traps (ETs) [20,22e26] . Macrophages have recently been discovered to produce macrophage ETs (METs) composed of nuclear DNA and histones, which are released in response to Gram-positive and Gram-negative bacteria and nano-particles [20, 22, 23] . Mast cells also produce ETs containing nuclear DNA, histones, tryptase, and cathelicidin LL-37 in response to Streptococcus pyogenes [25] . Interestingly, eosinophils produce ET composed of mitochondrial DNA rather than nuclear [24] ; although, some have demonstrated mitochondrial DNA is also found in NETs produced by neutrophils that do not die in the process of NET formation [27, 28] . Despite some differences between leukocyte traps, several authors have confirmed the ability of these ETs to trap and kill pathogens [20,23e26] .

Recent research from our laboratory has demonstrated that M. haemolytica, an important member of the BRD complex, causes the formation of ETs by bovine neutrophils and macrophages [20, 21] . ET formation is mediated at least in part by the M. haemolytica leukotoxin, a member of the RTX (repeats-in-toxin) family of exotoxins, produced by M. haemolytica [20, 21] . Here, we demonstrate that another BRD pathogen, H. somni, which does not produce an RTX exotoxin, also causes neutrophil and macrophage ET formation. We present data that that outer membrane vesicles (OMVs), and not LOS of H. somni, is required for NET formation.

Whole blood was collected by venipuncture from healthy Holstein cows housed at the University of WisconsineMadison Dairy Cattle Center using 0.38% (v/v) sodium citrate as anticoagulant. Blood was centrifuged at 2100Â g for 12 min and the buffy coat removed. The buffy coat, containing mononuclear cells, was suspended in Hank's balanced salt solution (HBSS; Cellgro, Manassas, VA) with 4 mM ethylenediaminetetraacetic (EDTA) (without calcium or magnesium), layered onto Histopaque-1083 (Sigmae Aldrich, Saint Louis, MO) and centrifuged at 2100Â g for 25 min at room temperature. Mononuclear cells were removed and contaminating red blood cells (RBCs) lysed in a 1:10 dilution of lysis buffer (150 mM ammonium chloride, 10 mM Tris (pH 7.5)) while rotating at 8 rpm for 10 min. Cells were pelleted at 1000Â g and washed 3Â in HBSS with 4 mM EDTA. Mononuclear cells were resuspended in RPMI-1649 (Cellgrow) with 1% FBS and incubated for 2 h on 100 mm carboxyl coated dishes (Becton, Dickinson and Company, Franklin Lakes, NJ). Nonadherent cells were removed by repeated washing and the medium replaced with 10% FBS, 100 U/ mL penicillin and 100 mg/mL streptomycin. The adherent monocytes were cultured for 7 days at 37 C, during which time the media was changed twice. Monocytes with greater than 99% viability, as determined by trypan blue staining and light microscopy, were deemed acceptable for further use.

Bovine neutrophils (bPMNs) were isolated by diluting the red blood cell (RBC) pellet in a 1:3 dilution of lysis buffer (150 mM ammonium chloride, 10 mM tris (pH 7.5)) while rotating at 8 rpm for 10 min. bPMNs were pelleted at 1000Â g and washed 4Â with Hank's balanced salt solution (HBSS; Cellgro, Mannasa, VA) to remove contaminating fibrinogen and platelets. Cells were resuspended in serum-and phenol red-free RPMI-1640 medium (Cellgro) and examined by light microscopy. A purity of >98% bPMNs was determined by microscopic inspection and >99% viability as determined by trypan blue exclusion.

H. somni (formally Haemophilus somnus) strain 649, generously provided by Dr. Lynette Corbeil, was initially isolated from a clinical case of bovine abortion. Bacteria were grown as previously described [29e31] . Briefly, a frozen aliquot of stationary-phase H. somni cells was thawed and inoculated into brain-heart infusion (BHI) broth supplemented with 0.5% yeast extract and 0.01% thiamine monophosphate (TMP; SigmaeAldrich). The bacteria were cultured without shaking for 16 h at 37 C with 5% CO 2 . .

Bacteria were washed 3Â and resuspended in RPMI-1640 without phenol red or serum. Bacteria were enumerated by growth on tryptic soy agar supplemented with 5% sheep red blood cells (RBCs; Becton Dickson).

Neutrophil extracellular DNA was quantified as previously described [21] . Briefly, neutrophils or macrophages were incubated for the indicated times with various stimuli and then pelleted at 250Â g for 3 min. The supernatant was removed, micrococcal nuclease buffer with 0.1 U/mL micrococcal nuclease was added (New England Biolabs, Ipswich, MA), and incubated for 15 min at 37 C (as described by the manufacturer). A 1:400 dilution of PicoGreen (Invitrogen, Calsbad, CA) in 10 mM Tris base buffered with 1 mM EDTA was added to an equal volume of the nucleasetreated leukocyte mixture. Fluorescence was determined at an excitation wavelength of 484 nm and an emission wavelength of 520 nm using an automated plate reader (DTX 800 Multimode detector, Beckman Coulter, Brea, CA). NET production was quantified as fold increase in DNA release compared to untreated control neutrophils.

DNase I (source: bovine pancreas), PMA, Escherichia coli lipopolysaccharide (LPS) and cytochalasin D were purchased from SigmaeAldrich. H. somni LOS was kindly provided by Dr. Tom Inzana (Blacksburg, VA) [32] . MPER was purchased from Pierce (Rockford, IL) and used to make bPMN lysates. LDH release was determined using CytoTox 96 Non-radioactive Cytotoxicity Assay as described by the manufacturer (Promega, Madison, WI).

To perform immunofluorescence microscopy, bPMNs (3 Â Following that slides were washed and examined by confocal microscopy (Nikon Eclipse TE2000-U, Nikon Corporation, Tokyo, Japan).

For scanning electron microscopy, bPMNs (3 Â 10 6 ) were incubated on poly-L-lysine coated glass slides for 30 min, washed twice with PBS and then incubated with 10 8 H. somni cells for 1 h. Slides were washed, fixed with 4% paraformaldehyde in PBS, post fixed with 2.5% glutaraldehyde, and prepared as previously described [21] . Images were taken with a Hitachi S900 at the Biological and Biophysical Preparation, Imaging and Characterization Laboratory at the University of Wisconsin e Madison (Hitachi, Japan).

H. somni cells were grown to log phase as described earlier, washed 3Â in PBS, and resuspended for 15 min on ice in 0.5 mg/mL fluorescein isothiocyanate (FITC; SigmaeAldrich) in 50 mM sodium carbonate buffer. The H. somni cells were then washed 3Â with PBS and resuspended at a concentration of 5 Â 10 9 bacteria/mL in serum-free RPMI-1640. Cell viability after FITC labeling was assessed by dilution plating both FITC-labeled and unlabeled H. somni cells. Dilutions were plated on blood agar and CFU estimated.

To inhibit phagocytosis, 10 mg/mL cytochalasin D was incubated at 37 C with 5% CO 2 for 30 min with bPMNs (10 6 ), the cells were then washed and resuspended in RPMI-1640 without phenol red or serum. As a control, cytochalasin D-treated and untreated bPMNs (10 6 ) were incubated for the length of the experiment with 180 U DNase I. Treated (Cyto D, DNase, Cyto D þ DNase) and untreated bPMNs were washed and then incubated with FITC-labeled or unlabeled H. somni cells (10 7 ) in RPMI-1640 for 60, 120 or 180 min at 37 C.

To quantify the bacterial cells trapped within NETs, samples were washed 3Â with PBS and fluorescence determined using an automated plate reader. To determine bacterial killing by NETs, bPMN were incubated with H. somni suspensions for various times at 37 C. Following this, samples were removed, were serially diluted in PBS and plated on TSA with 5% sheep RBC. As a control, H. somni was incubated in RPMI without bPMNs and samples removed and plated on blood agar to quantify total CFU. The percent bactericidal activity attributable to NETs was determined as described previously [12, 21] .

H. somni OMVs were prepared and purified as previously described [33] . Briefly, H. somni was grown to log phase in BHI broth supplement with 0.5% yeast extract and 0.01% TMP at 37 C with 5% CO 2 . The culture was centrifuged at 10,000Â g for 30 min, the supernatant collected and centrifuged again at 20,000Â g for 30 min. These cell-free supernatants were ultracentrifuged at 105,000Â g for 30 min at 4 C to collect the OMVs. H. somni OMNVs were dissolved in RPMI without phenol red and stored at À80 C until used in an experiment. Protein concentrations were determined using bicinchoninic acid (BCA) as described by the manufacture (Pierce).

Group means were compared by ANOVA, followed by the TukeyeKramer pairwise comparison test, as performed by the Instat statistical package (GraphPad, San Diego, CA). The level of significance was set at p < 0.05.

We observed NET formation in response to H. somni cells in both a dose-and time-dependent manner (Fig. 1) . To confirm that PicoGreen bound extracellular DNA, we incubated H. somni-treated bPMNs with DNase I, which cleaves extracellular DNA. As expected, DNase I reduced the PicoGreen fluorescence (Fig. 1) . We used cytochalasin D, an inhibitor of actin polymerization, to confirm NET formation results from the release of extracellular DNA. NET formation occurred in response to H. somni despite cytochalasin D treatment (Fig. 1) .

NET formation has been classified as independent of necrosis and apoptosis [7, 9] . During necrosis, significant lactate dehydrogenase (LDH) is released [7, 9] . We quantified LDH release and found little to no significant LDH release when bPMNs were incubated with H. somni cells (Fig. 1 C,D) . Likewise, NET formation was not inhibited when bPMNs were treated with Z-VAD-FMK, a pancaspase inhibitor of apoptosis (data not shown).

We and others have observed that 10e33% of human and bovine neutrophils undergo NET formation when exposed to a stimulus [8, 9] . We report previously that repeated exposure of bPMNs to M. haemolytica led to a significant increase in NET formation [21] . Here, we found a similar effect when bPMNs were repeatedly exposed to H. somni cells (Fig. 2A) . Furthermore, no significant LDH release was seen (Fig. 2B ).

H. somni has several virulence factors that contribute to its pathogenesis including lipooligosacchride (LOS) and outer membrane proteins that are found in OMVs [5] .We purified H. somni OMVs and incubated these with bPMNs at various concentrations and for various times. We observed a dose-and time-dependent increase in NET formation in response to purified H. somni vesicles (Fig. 3) . Various molecules are found in OMVs including LOS, immunoglobulin-binding protein (IbpA) and others [6] . The ability of lipopolysacchride (LPS) to cause NET formation has been controversial, with some authors demonstrating a need for a second stimulus [28, 34] . Recently, purified LOS from nontypable Haemophilus influenzae was reported to cause NET formation by human neutrophils [35] . We did not observe NET formation when bPMNs were incubated with various concentrations of LOS (kind gift from Dr. Inzana) for 2 h at 37 C (data not shown). Nontypable H. influenzae LOS required 5 h of incubation to trigger NET formation [35] . We tried various concentrations (10 pge70 mg) of H. somni LOS for up to 8 h and did not observe NET formation at any concentration or time point (data not shown). These data indicate that OMVs cause NET formation, but LOS alone is not the causative agent.

Several authors have found that bPMNs trap and kill pathogens [12, 14, 21] . Here, we found that H. somni cells were trapped and killed by bovine NETs in a time-dependent manner ( Fig. 4 A,B) . As expected, bPMNs treated with DNase I, to degrade extracellular DNA, had a reduced ability to trap and kill H. somni cells (Fig. 4 C,D) . bPMNs treated with cytochalasin D were able to trap and kill H. somni, although at a reduced level compared to untreated bPMNs (Fig. 4 C,D) . Treatment of cytochalasin D-treated bPMNs with DNase I did reduce NET-mediated trapping and killing (Fig. 4 C,D) .

We used scanning electron microscopy (SEM) to examine the ultrastructure of the H. somni-induced NETs. H. somni-treated bPMNs produced NETs that ensnared H. somni cells (see arrows) in a web-like structure where some fibrils are longer than 20 mm (Fig. 5A) . In a higher magnification picture, H. somni cells are seen trapped in fibrils of DNA that appear to be extruded from a bPMN (Fig. 5B) . Untreated bPMNs did not produce NETs (Fig. 5C) . Similarly, using confocal microscopy we found H. somni caused NET formation by approximately 25% of bPMNs (Fig. 6 ). We also found H. somni cells (green) trapped within a matrix of DNA (red). Addition of DNase I freed the bacterial cells from the matrix (Fig. 6A ). NETs were also observed when bPMNs were incubated with H. somni OMVs and PMA, but not in response to H. somni LOS (Fig. 6 ).

Recently, we and other researchers have demonstrated that human [22] , murine [23] , and bovine macrophages [20] produce macrophage extracellular traps (METs) in response to various stimuli. We found that H. somni cells caused the formation of METs by bovine monocyte-derived macrophages in a dose-dependent manner (Fig. 7) . MET formation was reduced when bovine macrophages were incubated with DNase I, which cleaves extracellular DNA, but was not affected when bovine macrophages were incubated with cytochalasin D (Fig. 7) .

The results of this study add H. somni to the list of pathogens that cause NET formation [12, 14] . In particular, M. haemolytica, a primary bacterial pathogen that causes BRD, has been shown to cause NET and MET formation [20, 21] . NET formation is believed to be an active form of cell death that is independent of necrosis and apoptosis. Extracellular DNA release by bPMNs in response to H. somni cells occurred without significant release of LDH, implicating NET formation rather than necrosis as the cause for extracellular DNA (Fig. 1) . Similarly, cytochalasin D did not significantly diminish NET formation in response to H. somni cells (Fig. 1) , which others have argued is a hallmark for NETosis [7, 9] . Nor was NET formation significantly diminished when the pan-caspase inhibitor, Z-FAD-FMK, was added to inhibit apoptosis (data not shown) [9] . The amount of extracellular DNA was reduced when bovine DNase I was incubated with NETs produced in response to H. somni cells (Fig. 1) . Repeated exposure to H. somni cells (hourly for up to 6 h) further increased NET formation without a significant increase in LDH release (Fig. 2) . M. haemolytica, another BRD pathogen, elicits a similar response when bPMNs are repeatedly exposed to M. haemolytica cells [21] .

An important virulence factor for H. somni is its truncated lipopolysacchride, LOS, which has been shown to activate caspase-3 and -8 and induce apoptosis in bovine endothelial cells [36e38] . LOS has also been demonstrated to induce platelet aggregation and activation leading to endothelial cell death and a proinflammatory response [39e42]. Interestingly, NET formation was not observed in response to purified H. somni LOS at various concentrations (10 pge 70 mg) nor for various lengths of time (10 mine8 h) (data not shown). Our findings differ from a report that found LOS purified from H. influenzae causes NET formation in a model of otitis media [35] , and alters the ability of NETs to kill H. influenzae cells. Mutants of H. influenzae, with LOS core and lipid A assembly defects, were more susceptible to NET killing than H. influenzae with native LOS. These date indicate that LOS may cause NET formation, but the NETs formed are limited in their ability to kill H. influenzae cells [43] . H. influenzae [44e46] and H. somni [47e49] both undergo random phase and antigenic variation of the LOS in vitro or in response to the specific host immune response leading to changes in the composition or structure of the LOS [50e52]. H. somni LOS can also be modified by the addition of phosphorylcholine, which has been demonstrated to be important for colonization of the bacteria to bovine upper respiratory tract [32] and platelet aggregation [39] . Here, we did not observe NET formation in response to LOS purified from H. somni 649, which produces LOS with phosphorylcholine modifications. OMVs have recently been studied as vaccine candidates for various Gram-negative pathogens such as Neisseria meningitidis, Shigella boydii, and Vibrio cholerae [53e59]. We examined whether H. somni OMVs, containing outer membrane proteins and cytosolic components, could cause NET formation. We found that H. somni OMVs stimulated NET formation in a dose-and time-dependent response, although the response varied among experiments (Fig. 3) . Corbeil and colleagues [60e62] have demonstrated that recombinant immunoglobulin-binding protein (IbpA) subunits protect calves and mice from severe H. somni disease. Vaccination of calves with three subunits of IbpA (A3, A5, and DR2) led to a lower percentage of gross lesions and histological abnormalities than control calves and H. somni was not recovered from these pneumonic lesions [62] . Because IbpA is secreted in OMVs, future investigations could address the role of IbpA and other OMV proteins in NET formation.

NETs have been reported to trap and kill a variety of bacteria, parasites, and fungi (for a review see [18] ). Here, we demonstrate that bPMNs trap and kill H. somni cells in a time-dependent manner (Fig. 4) . Incubation of NET with DNase I reduced DNA-mediated trapping and killing, indicating that most bacterial cells (>40%) were killed in NETs rather than by phagocytosis. Pre-incubation of bPMNs with cytochalasin D, an inhibitor of actin polymerization, did not significantly reduce the trapping and killing of H. somni cells. Cytochalasin D inhibits phagocytosis, but not NET formation, providing further evidence that most bacterial cells are trapped and killed via NET formation (Fig. 4) . H. somni has been known to be rather resistant to killing via phagocytosis [5] . Perhaps NET formation is a more prominent form of controlling H. somni in vivo.

It has been long noted that BRD pathogens cause clusters of "streaming leukocytes" within the alveoli of infected cattle [63, 64] . These elongated leukocytes with streaming nuclei are also referred to as "oat cells" [63, 64] in which the origins of the streaming leukocytes were mostly produced from neutrophils, with some arising from macrophages [65] . Histological section of a BRD lung also showed extensive neutrophil infiltration and vast amounts of extracellular DNA that have been theorized to be produced by "streaming leukocytes" [21] . Here, we provide photomicrographs that demonstrate elongated bPMNs having a similar morphological structure in vitro as previously reported as 'streaming leukocytes' [63e66]. Extracellular DNA (i.e. "streaming nuclei") are seen that have trapped H. somni cells (Figs. 5 and 6 (see arrows)). Using confocal microscopy, we confirm that approximately 25e30 percent of bPMNs form NETs when incubated with H. somni cells, H. somni OMVs, or PMA, but not when incubated with H. somni LOS (Fig. 6) . These data are similar to previous reports in which 10 to 33 percent of neutrophils underwent NET formation [8, 9, 21] . We infer that 'streaming leukocytes' and free DNA found in the alveolar spaces of BRD afflicted cattle [21] reflect in part NET formation elicited by BRD pathogens such as H. somni or M. haemolytica.

Recently, macrophages have been demonstrated to produce ETs in response to various stimuli [20, 22, 23] , including M. haemolytica [20] . Here, we demonstrate that another BRD pathogen, H. somni, also causes MET formation by bovine monocyte-derived bovine macrophages (Fig. 7) . We also observed MET formation by bovine alveolar macrophages in response to H. somni (data not shown). Macrophages are sentinel cell in the lungs and other tissue sites that detect invaders and release chemoattractant proteins for other leukocytes including neutrophils. The role METs play in the recruitment of inflammatory leukocytes has not been investigated.

The benefits of NETs have been demonstrated primarily by their ability trap and kill various pathogens in vitro [18, 19] . However, it has been suggested that NETs may play a role in vasculitis, deep vein thrombosis (DVT), systemic lupus erythematosous, preeclampsia, gout and arthritis [67e75]. These observations may be relevant to the pathogenesis of H. somni infection, which produces a wide array of clinical syndromes including arthritis, vascular inflammation, multiple thrombotic lesions and an acute form of vasculitis called thrombotic meningoencephalitis (TME). The latter is characterized by fibrinopurulent meningitis with abscess formation, hemorrhaging, and thrombotic vasculitis throughout the central nervous system that can result in death within 12e24 h after the onset of symptoms [4] . It has been demonstrated that deposition of NETs in inflamed kidneys, and circulating myeloperoxidase-DNA complexes, can trigger vasculitis and promote an autoimmune response against neutrophil components [69] . Similarly, others have demonstrated that histones and chromatin, which are present in NETs, cause up regulation of thrombin leading to venous thrombi formation in mice that is similar to DVT seen in humans [76] . Interestingly, intravenous administration of histones exacerbated DVT formation, but administration of DNase I, which degrades NETs, protected mice from venous thrombosis [76] . Neutrophils from human cancer patients treated with granulocyte colony-stimulating factor (G-CSF) are sensitized to form NETs upon exposure to a second stimulus, leading to a prothrombotic state in these patients [71] . Platelet-induced NET formation has also been implicated in thrombus formation in a mouse model of transfusionrelated acute lung injury, where the administration of an antihistone antibody and DNase I protected mice for acute lung injury [77] . The connection between H. somni-induced vasculitis or TME and NET formation has not been addressed; however, further research should focus on how NETs may play a role in the vascular syndromes seen in H. somni infected animals. Perhaps, DNase I should be examined to determine if DNase I could alleviate vascular symptoms.

The results of this study provide a new perspective to older observations regarding the interactions of bovine neutrophils and macrophages with H. somni. Several reports indicated that bovine neutrophil function was inhibited by various components of H. somni (then called H. somnus) [78e82]. Despite being a somewhat fastidious organism in the laboratory, H. somni was resistant to killing by bovine neutrophils and mononuclear phagocytes. This resistance was attributed to a weak oxidative burst by neutrophils in the presence of metabolically active H. somni, or high and low molecular weight fractions released from the organism [83] . Bovine macrophages also were ineffective at killing H. somni and could support limited intracellular multiplication of the organism [84] . Despite these in vitro observations, it is clear that host innate defense mechanisms are able to restrict growth of H. somni in the respiratory tract and at other sites, as the infections tend to be subacute rather than acute in onset (except for TME) [4, 5, 50] . The observations in the present study may illustrate one way in which neutrophils and macrophages can battle effectively with H. somni. If the organism triggers extracellular trap formation in vivo, similar to what was observed in vitro, this could provide one means by which the host restrains multiplication and slows the progression of H. somni infection.

Economic, clinical and functional consequences of a treatment using metrenperone during an outbreak of shipping fever in cattle

A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease of cattle

Microbiologic investigations of natural epizootics of shipping fever of cattle

The Haemophilus somnus disease complex (Hemophilosis): a review

Haemophilus somnus virulence factors and resistance to host immunity

Histophilus somni IbpA DR2/Fic in virulence and immunoprotection at the natural host alveolar epithelial barrier

Neutrophil extracellular traps kill bacteria

Beneficial suicide: why neutrophils die to make NETs

Novel cell death program leads to neutrophil extracellular traps

Chicken heterophil extracellular traps (HETs): novel defense mechanism of chicken heterophils

Mouse neutrophil extracellular traps in microbial infections

Beta-hydroxybutyrate abrogates formation of bovine neutrophil extracellular traps and bactericidal activity against mammary pathogenic Escherichia coli

Isolation and functional characterization of neutrophil-like cells, from goldfish (Carassius auratus.) kidney

Neutrophil extracellular trap formation by bovine neutrophils is not inhibited by milk

Zebrafish (Danio rerio) whole kidney assays to measure neutrophil extracellular trap release and degranulation of primary granules

Fish cast NETs: neutrophil extracellular traps are released from fish neutrophils

Characterization of neutrophil extracellular traps in cats naturally infected with feline leukemia virus

Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality

Neutrophil extracellular traps mediate a host defense response to human immunodeficiency virus-1

Mannheimia haemolytica and its leukotoxin cause macrophage extracellular trap formation by bovine macrophages

Mannheimia haemolytica and its leukotoxin cause neutrophil extracellular trap formation by bovine neutrophils

Phagocytosis independent extracellular nanoparticle clearance by human immune cells

Statins enhance formation of phagocyte extracellular traps

Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense

Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation

Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis

Neutrophil extracellular traps contain mitochondrial as well as nuclear DNA and exhibit inflammatory potential

Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps

Haemophilus somnus activation of brain endothelial cells: potential role for local cytokine production and thrombosis in central nervous system (CNS) infection

Viable Haemophilus somnus induces myosin light-chain kinase-dependent decrease in brain endothelial cell monolayer resistance

Roles of cellular activation and sulfated glycans in Haemophilus somnus adherence to bovine brain microvascular endothelial cells

Molecular characterization of phosphorylcholine expression on the lipooligosaccharide of Histophilus somni

Immunological characterization of the major outer membrane protein of Haemophilus somnus

Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood

Nontypeable Haemophilus influenzae initiates formation of neutrophil extracellular traps

Haemophilus somnus induces apoptosis in bovine endothelial cells in vitro

Stimulation of P2X receptors enhances lipooligosaccharide-mediated apoptosis of endothelial cells

Caspase activation during Haemophilus somnus lipooligosaccharide-mediated apoptosis of bovine endothelial cells

Expression of phosphorylcholine by Histophilus somni induces bovine platelet aggregation

Platelet activation by Histophilus somni and its lipooligosaccharide induces endothelial cell proinflammatory responses and platelet internalization

Bovine platelets activated by Haemophilus somnus and its LOS induce apoptosis in bovine endothelial cells

Endothelial cell apoptosis induced by bacteria-activated platelets requires caspase-8 and -9 and generation of reactive oxygen species

Survival of bacterial biofilms within neutrophil extracellular traps promotes nontypeable Haemophilus influenzae persistence in the chinchilla model for otitis media

Prognostic impact of phosphorylcholine expression in nontypeable Haemophilus influenzae in otitis media with effusion

Evaluation of phase variation of nontypeable Haemophilus influenzae lipooligosaccharide during nasopharyngeal colonization and development of otitis media in the chinchilla model

Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein

Antigenic diversity of Haemophilus somnus lipooligosaccharide: phase-variable accessibility of the phosphorylcholine epitope

Genetics and molecular specificity of sialylation of Histophilus somni lipooligosaccharide (LOS) and the effect of LOS sialylation on Toll-like receptor-4 signaling

Structural analysis of the lipooligosaccharidederived oligosaccharide of Histophilus somni (Haemophilus somnus) strain 8025

Phenotypic phase variation in Haemophilus somnus lipooligosaccharide during bovine pneumonia and after in vitro passage

Phase variation and conservation of lipooligosaccharide epitopes in Haemophilus somnus

Purification and characterization of lipooligosaccharides from four strains of Haemophilus somnus

Platelet-platelet and platelet-leukocyte interactions induced by outer membrane vesicles from N. meningitidis

Outer membrane vesicles of Shigella boydii type 4 induce passive immunity in neonatal mice

Identification and optimization of critical process parameters for the production of NOMV vaccine against Neisseria meningitidis

Characterization of outer membrane vesicles from Brucella melitensis and protection induced in mice

Immunization of mice with Vibrio cholerae outer-membrane vesicles protects against hyperinfectious challenge and blocks transmission

Outer membrane vesicles of Porphyromonas gingivalis elicit a mucosal immune response

Gram-negative outer membrane vesicles in vaccine development

Protection of mice against H. somni septicemia by vaccination with recombinant immunoglobulin binding protein subunits

Antibody responses of calves to Histophilus somni recombinant IbpA subunits

IbpA DR2 subunit immunization protects calves against Histophilus somni pneumonia

Protection of ruminants by Pasteurella haemolytica A1 capsular polysaccharide vaccines containing muramyl dipeptide analogs

Expression of the neutrophil chemoattractant interleukin-8 in the lesions of bovine pneumonic pasteurellosis

Distribution of anti-CD68 (EBM11) immunoreactivity in formalin-fixed, paraffin-embedded bovine tissues

Immunohistochemical detection of Mannheimia (Pasteurella) haemolytica antigens in goats with natural pneumonia

Occurrence of neutrophil extracellular DNA traps (NETs) in pre-eclampsia: a link with elevated levels of cell-free DNA?

Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis

Netting neutrophils in autoimmune small-vessel vasculitis

Diagnostic accuracy of neutrophil-derived circulating free DNA (cf-DNA/NETs) for septic arthritis

Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis

Neutrophil extracellular trap (NET) impact on deep vein thrombosis

Extracellular DNA traps promote thrombosis

Lupus neutrophils: 'NET' gain in understanding lupus pathogenesis

Neutrophil extracellular trap formation is associated with IL-1beta and autophagy-related signaling in gout

Neutrophil extracellular traps promote deep vein thrombosis in mice

Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury

Modulation of phagocytic function of bovine mononuclear phagocytes by Haemophilus somnus

Inhibition of bovine macrophage and polymorphonuclear leukocyte superoxide anion production by Haemophilus somnus

Effect of Haemophilus somnus on phagocytosis and hydrogen peroxide production by bovine polymorphonuclear leukocytes

Elimination of hydrogen peroxide by Haemophilus somnus, a catalase-negative pathogen of cattle

Identification of suppressive components in Haemophilus somnus fractions which inhibit bovine polymorphonuclear leukocyte function

Bovine neutrophils ingest but do not kill Haemophilus somnus in vitro

Haemophilus somnus, a facultative intracellular pathogen of bovine mononuclear phagocytes